Abstract:Objective: To explore the gene mutation characteristics and detailed clinical presentations of hyperglycemia caused by GCK mutations in 10 patients. Methods: The clinical and follow-up data of 10 patients with hyperglycemia caused by mutation of GCK gene were reviewed. The patients were ascertained between January 1, 2014 and August 31, 2018 at the Department of Pediatrics, the First Affiliated Hospital of Zhejiang University and Ningbo Women & Children's Hospital. Clinical data were collected, including age, gender, main complaint, family history, fasting blood glucose, fasting blood insulin, 2-hour blood glucose, 2-hour blood insulin after oral glucose tolerance test, glycosylated hemoglobin, anti-glutamic acid decarboxylase antibody and body mass index. Mutations of GCK gene were detected by Sanger sequencing or high-throughput sequencing of diabetes-related genes in the patients and their family members. Results: There were ten patients, 8 of them were male, 2 were female.The ages at diagnosis varied between 4.7 to 12.3 years. The patients usually did not have obvious clinical symptoms of diabetes mellitus. Most of them were unexpectedly found to have hyperglycemia and with impaired glucose metabolism in three consecutive generations. The fasting blood glucose of patients was 6.8-7.7 mmol/L, 2-hour postprandial blood glucose was 7.8-11.6 mmol/L. Fasting blood insulin was 0.5-8.5 mU/L, glucose tolerance test results showed that 2 h postprondial blood insulin was 1.3-55.4 mU/L. The level of glycosylated hemoglobin was 6.1%-6.8%. Anti-glutamic acid decarboxylase antibody was negative in all patients. The GCK mutations identified in patients and one of their parents were located at exon5 (4 cases), exon9 (2 cases), exon2 (1 case), exon4 (1 case), exon6 (1 case) and exon7 (1 case). Conclusions: Most of the hyperglycemia patients caused by GCK mutations did not have typical clinical symptoms of diabetes. The fasting blood glucose was slightly elevated. Abnormal glucose tolerance test results were found in all 10 patients. Three consecutive generations of family had impaired glucose metabolism. GCK mutations located at exon 5 were common in 10 cases. There was no correlation between type of mutations and plasma glucose levels in domestic and international researches. When fasting glucose was found abnormal in clinic, a complete family history should be taken and the GCK gene should be sequenced to confirm the diagnosis in time.

Gene mutation and clinical study in the patients with glycogen storage disease type Ⅰ a

A Novel Type Heterozygous Mutation in the Glucose-6-phosphatase Gene in a Chinese Patient with Glycogen Storage Disease Ia.

Glycogen storage disease typeⅠa:a pedigree study

Three novel mutations of the G6PC gene identified in Chinese patients with glycogen storage disease type Ia

[Hyperglycemia Caused by Mutation of GCK Gene in 10 Patients Analysis of Clinical and Mutation Characteristics].

A Novel Homozygous No-Stop Mutation in G6pc Gene from A Chinese Patient with Glycogen Storage Disease Type Ia

Clinical and genomic study of the infant with glycogen storage disease typeⅡ

[Clinical Features and Acid Alpha-Glucosidase Gene Mutation in 7 Chinese Patients with Glycogen Storage Disease Type II].

Molecular genetics of glycogen-storage disease type 1a in Chinese patients of Taiwan

Clinical features and PHKG2 gene mutation analysis of 5 Chinese patients with glycogen storage disease Ⅸc

Molecular Genetic Analysis of 10 Chinese Patients with Glycogen Storage Disease Type Iii

Genotypic and phenotypic characteristics of 12 chinese children with glycogen storage diseases

Glycogen storage disease type Ia: recent experience with mutation analysis, a summary of mutations reported in the literature and a newly developed diagnostic flowchart

Mutations in the glucose-6-phosphatase gene of 53 Italian patients with glycogen storage disease type Ia

Prenatal Diagnosis of Glycogen Storage Disease Ia by Screening for Hot Spot Mutations in Combination with the 1176 Nucleotide Polymorphism Linkage Analysis

Genotypic and phenotypic features of 39 Chinese patients with glycogen storage diseases type I, VI, and IX

Clinical and genetic features of patients with glycogen storage disease type Ⅸa:An analysis of 20 cases

Report of 7 cases of glycogen storage disease type VI and type IXa

Genetic Analysis and Clinical Assessment of Four Patients with Glycogen Storage Disease Type IIIa in China

Molecular, Biochemical, and Clinical Characterization of Thirteen Patients with Glycogen Storage Disease 1a in Malaysia

Predominance of the c.648G > T G6PC gene mutation and late complications in Korean patients with glycogen storage disease type Ia